Bacillus cereus is a rare cause of endocarditis, typically associated with intravenous drug abuse, rheumatic heart disease, prosthetic heart valves, pacemakers, or immunodeficiency. We present the first case of native valve Bacillus cereus endocarditis with no apparent risk factors. The patient had a fulminant course requiring emergent valve replacement.
valve was accomplished with a 23-mm Carbomedics mechanical bileaflet top-hat valve.
Bacillus cereus was identified in two sets of blood cultures. The B. cereus group consists of closely related species: B. anthracis, B. cereus, B. thuringiensis, and B. mycoides. The members of the group are difficult to separate phenotypically and are closely related genotypically. Phenotypic testing consisted of macroscopic and microscopic morphologies in culture and Gram stain, motility, and special media. Genotypic testing consisted of nucleic acid sequencing accomplished using 16S rRNA sequencing (i.e., MicroSeq short-sequence [500 bp] analysis followed by full gene sequencing). Both approaches were used in the final bacterial identification. The finding of B. cereus prompted a change in the patient's antibiotics to daptomycin and ceftriaxone based upon the antibiogram. The organism was resistant to penicillin and tetracycline and was sensitive to cephalosporins, aminoglycosides, levofloxacin, linezolid, sulfamethoxazole-trimethoprim, and vancomycin. Pathological analysis of the tricuspid aortic valve contained acute inflammatory and fibrinous vegetations, granulation tissue, and fibrosis consistent with endocarditis. Gram stain and culture did not yield definite causative bacteria or intracellular bacteria.
Following valve replacement, the patient made an excellent clinical recovery and received ceftriaxone for 6 weeks of outpatient IV antibiotic therapy.
Bacillus cereus is an aerobic or facultative anaerobic, sporeforming, Gram-positive rod that is ubiquitously found throughout the natural environment (i.e., in the soil). Bacillus species can also commonly be found in the hospital environment (i.e., dressings, intravenous catheters, and linens), on personal products (i.e., contact lens solution), and even in the mucous membranes of healthy adults (2, 7, 12, 14, 16) . Sometimes dismissed as a contaminant, the organism has been identified as a pathogen in a wide variety of illnesses (7) . Broadly divided, the organism is responsible for gastrointestinal and nongastrointestinal diseases (7) . Among the gastrointestinal illnesses, Bacillus cereus is classically responsible for the onset of nausea and profuse vomiting after consuming rice (or other starchy food) secondary to its preformed, heat-stable emetic toxin. Nongastrointestinal Bacillus cereus infections have caused serious and sometimes fatal illnesses, such as pneumonia, meningitis, encephalitis, and brain abscesses (7) .
Bacillus cereus is a rare cause of endocarditis, and when found to be the causative pathogen, is typically associated with preexisting valvular disease (rheumatic heart disease) (17) , prosthetic heart valves (3, 4, 10, 11, 13, 19) , a history of intravenous drug abuse (6, 15, 18) , pacemakers (1, 12) , or leukemia (5) ( Table 1) .
To our knowledge, there have been no prior case reports of native valve Bacillus cereus endocarditis in a patient without these risk factors. Discussion. Finland and Barnes reported the first cases of Gram-positive bacillus endocarditis in 1933 (two cases) and in 1951 (one case) at Boston City Hospital. Characterized as miscellaneous causes of endocarditis at that time, these first two cases occurred before the introduction of highly potent antibacterial drugs, and thus both patients died (9). Farrar's review in 1963 of nonpathogenic organisms of the genus Bacillus marked the beginning of the widespread recognition of nonanthrax Bacillus spp. as causing pathogenic human disease (8) .
Bacillus cereus endocarditis was first reported in 1974 in an IV drug-abusing (IVDA) patient (6) . Since then, five additional cases have been reported in the literature. Bacteremia in IVDA patients is likely acquired from skin colonization, contamination of the injection equipment, or organisms in the heroin itself. Tuazon et al. showed that Bacillus spp. could be cultured from 32% of heroin samples and 47% of injection drug paraphernalia (14) . To date, all of the patients with IVDA-associated, native valve Bacillus cereus endocarditis received effective antibiotic therapy, and none of them died or required emergent valve replacement. The mantra has been that IVDA-associated endocarditis responds extremely well to antibiotic therapy alone, whereas that associated with prosthetic valves has much higher morbidity and mortality rates and usually requires surgical intervention. Our report describes the first case of native valve endocarditis in which a patient did not respond initially to antibiotic therapy alone and required emergent valve replacement due to hemodynamic instability.
Bacillus cereus endocarditis associated with prosthetic valves has been reported a total of six times. The first case, in 1978, was treated with antibiotic therapy alone, and the patient died secondary to septic emboli (3) . Subsequently, all patients have been treated with valve replacement and made good recoveries; hence, it is recommended that prompt valve replacement surgery be considered to reduce high morbidity and mortality rates associated with Bacillus cereus prosthetic valve endocarditis (4) .
In general, Bacillus cereus endocarditis appears to typically fol- low a benign course and generally responds to antibiotic treatment alone. Penicillins and cephalosporins are traditionally avoided as initial therapy given the high incidence of resistance to these agents. Out of the antimicrobial agents in routine use today, Bacillus cereus appears to be nearly uniformly sensitive to aminoglycosides, clindamycin, erythromycin, and vancomycin. Of the 17 cases reported, three have died. Those patients that died include one with rheumatic heart disease (RHD), another with leukemia, and the last with a mechanical valve. All of these cases were treated with antibiotics alone, and surgery for valve replacement was not performed. Conclusion. In our case report of native valve Bacillus cereus endocarditis, the etiology of septicemia and subsequent seeding of the aortic valve remains elusive. The patient lacked typical predisposing factors and had no signs or symptoms of immunodeficiency. Given the review of systems obtained from the patient and physical exam findings, possible portals of entry include infectious diarrhea or odontogenic infection, although both of these seem unlikely.
Historically, IVDA-associated Bacillus cereus endocarditis has responded well to antibiotics alone, without the need for surgical intervention. Our case highlights an aggressive case of native-valve Bacillus cereus endocarditis and the need for prompt consideration of valve replacement if the patient is hemodynamically unstable or is experiencing large numbers of septic emboli.
